Chronic Kidney Disease Ckd Associated With Type 2 Diabetes T2d — Patent Landscape
2
Approved drugs
70
Active US patents
39/100
Avg vulnerability
$1.4B
Annual revenue covered
Originators in Chronic Kidney Disease Ckd Associated With Type 2 Diabetes T2d
Cliff calendar — next 15 years
20
27
20
28
20
29
4
30
3
33
3
35
Approved drugs ranked by patent estate
| Drug | Originator | Active patents | Avg vuln | Revenue | First cliff |
|---|---|---|---|---|---|
|
Invokana
CANAGLIFLOZIN
|
Johnson & Johnson | 64 | 65 | $800M | 2027-07-14 |
|
Kerendia
FINERENONE
|
Bayer | 6 | 13 | $600M | 2033-08-26 |
Most attackable patents
| Patent | Drug | Type | Vuln | Expiry |
|---|---|---|---|---|
| 8513202 | Invokana | method of use | 80 | 2027-12-03 |
| 8513202 | Invokana | method of use | 80 | 2027-12-03 |
| 8513202 | Invokana | method of use | 80 | 2027-12-03 |
| 8513202 | Invokana | method of use | 80 | 2027-12-03 |
| 8513202 | Invokana | method of use | 80 | 2027-12-03 |
| 8513202 | Invokana | method of use | 80 | 2027-12-03 |
| 7943582 | Invokana | method of use | 80 | 2029-02-26 |
| 7943582 | Invokana | method of use | 80 | 2029-02-26 |
| 7943582 | Invokana | method of use | 80 | 2029-02-26 |
| 7943582 | Invokana | method of use | 80 | 2029-02-26 |
Strongest defences
| Patent | Drug | Type | Vuln | Expiry |
|---|---|---|---|---|
| 8436180 | Kerendia | composition of matter | 4 | 2033-08-26 |
| 8436180 | Kerendia | composition of matter | 4 | 2033-08-26 |
| RE49826 | Kerendia | composition of matter | 17 | 2035-07-29 |
| RE49826 | Kerendia | composition of matter | 17 | 2035-07-29 |
| RE49826 | Kerendia | composition of matter | 17 | 2035-07-29 |
| 8436180 | Kerendia | composition of matter | 17 | 2033-08-26 |
| 7943788 | Invokana | composition of matter | 17 | 2027-07-14 |
| 7943788 | Invokana | composition of matter | 17 | 2027-07-14 |
| 7943788 | Invokana | composition of matter | 17 | 2027-07-14 |
| 7943788 | Invokana | composition of matter | 17 | 2027-07-14 |
Related
- Chronic Kidney Disease Ckd Associated With Type 2 Diabetes T2d — full disease profile
- AI Patent Landscape Report — type "chronic kidney disease ckd associated with type 2 diabetes t2d " for an AI exec memo
- Company Patent Rankings
- Biosimilar Opportunity Scanner